Variant report
Variant | nsv585766 |
---|---|
Chromosome Location | chr20:25944966-25952310 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM182A-1 | chr20:25945639-25949924 | ENSG00000226203 |
2 | lnc-FAM182A-1 | chr20:25945639-25949923 | XLOC_013502 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531174158 | chr20:25945644-25945645 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs73599900 | chr20:25945680-25945681 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs551170697 | chr20:25945710-25945711 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs376269620 | chr20:25945711-25945712 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs577025061 | chr20:25945712-25945713 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs370362849 | chr20:25945720-25945721 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs534848401 | chr20:25945721-25945722 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs536916658 | chr20:25945730-25945731 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs546698104 | chr20:25945742-25945743 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs374120849 | chr20:25945745-25945746 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs151028537 | chr20:25945776-25945777 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs533247267 | chr20:25945779-25945780 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs146432255 | chr20:25945791-25945792 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs73599901 | chr20:25945807-25945808 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs370382978 | chr20:25945808-25945809 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs569006826 | chr20:25945817-25945818 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs56787461 | chr20:25945841-25945842 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs73599902 | chr20:25945853-25945854 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs66738921 | chr20:25945865-25945866 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs73601703 | chr20:25945906-25945907 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs554329416 | chr20:25945908-25945909 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs73620349 | chr20:25945931-25945932 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs73601704 | chr20:25945974-25945975 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs73601705 | chr20:25945979-25945980 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs73601706 | chr20:25945995-25945996 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs574661442 | chr20:25946037-25946038 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs6132908 | chr20:25946058-25946059 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs73601707 | chr20:25946075-25946076 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs6107111 | chr20:25946090-25946091 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs73601708 | chr20:25946093-25946094 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs553496263 | chr20:25946112-25946113 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs73601709 | chr20:25946115-25946116 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs149264147 | chr20:25946133-25946134 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs545809748 | chr20:25946134-25946135 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs4815489 | chr20:25946153-25946154 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs4815490 | chr20:25946160-25946161 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs73601710 | chr20:25946161-25946162 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs377491289 | chr20:25946162-25946163 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs4813593 | chr20:25946165-25946166 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs188915495 | chr20:25946171-25946172 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs4815491 | chr20:25946187-25946188 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs73601711 | chr20:25946204-25946205 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs567045178 | chr20:25946233-25946234 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs73601712 | chr20:25946260-25946261 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs532417690 | chr20:25946273-25946274 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs111761967 | chr20:25946290-25946291 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs73601713 | chr20:25946322-25946323 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs73601714 | chr20:25946326-25946327 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs73601715 | chr20:25946370-25946371 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs79301704 | chr20:25946416-25946417 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:25945800-25946200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
2 | chr20:25946000-25946400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |